Med-X (MXRX) Current Deferred Revenue: $0.00 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Med-X Current Deferred Revenue?

Med-X MXRX Current Deferred Revenue is $0.00 Mil as of Dec. 2022.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Med-X's current deferred revenue for the quarter that ended in Dec. 2022 was $0.00 Mil.

Med-X Current Deferred Revenue Related Terms

Med-X Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Med-X's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med-X Current Deferred Revenue Chart

Med-X Annual Data
Trend Dec20 Dec21 Dec22
Current Deferred Revenue
0.00 0.00 0.00

Med-X Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22
Current Deferred Revenue 0.00 0.00 0.00 0.00 0.00
What does a Current Deferred Revenue of $0.00 Mil mean?
Med-X (MXRX) has a Current Deferred Revenue of $0.00 Mil as of Dec. 2022. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Med-X and its competitors.
Is Med-X's Current Deferred Revenue too high?
Med-X's current Current Deferred Revenue is $0.00 Mil.
How does Med-X's Current Deferred Revenue compare to ?
Med-X's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Consumer Packaged Goods company?
A good Current Deferred Revenue depends on the Consumer Packaged Goods industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Med-X and its competitors. Med-X's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current Current Deferred Revenue of $0.00 Mil. The current Current Deferred Revenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Med-X (MXRX), the current Current Deferred Revenue is $0.00 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med-X Business Description

Comparable Companies
Address 8236 Remmet Avenue, Canoga Park, CA, USA, 91304
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.